Compare INFU & HGLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INFU | HGLB |
|---|---|---|
| Founded | 2005 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 182.4M | 208.3M |
| IPO Year | N/A | N/A |
| Metric | INFU | HGLB |
|---|---|---|
| Price | $8.63 | $8.99 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $14.50 | N/A |
| AVG Volume (30 Days) | ★ 118.2K | 91.8K |
| Earning Date | 03-03-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 13.16% |
| EPS Growth | ★ 271.43 | N/A |
| EPS | ★ 0.26 | N/A |
| Revenue | ★ $141,054,000.00 | N/A |
| Revenue This Year | $8.82 | N/A |
| Revenue Next Year | $2.90 | N/A |
| P/E Ratio | $33.35 | ★ N/A |
| Revenue Growth | ★ 6.23 | N/A |
| 52 Week Low | $4.61 | $6.42 |
| 52 Week High | $11.04 | $9.45 |
| Indicator | INFU | HGLB |
|---|---|---|
| Relative Strength Index (RSI) | 44.51 | 45.32 |
| Support Level | $8.34 | $8.83 |
| Resistance Level | $8.82 | $9.10 |
| Average True Range (ATR) | 0.36 | 0.24 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 42.96 | 71.44 |
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-reportable segment. The first is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second, Device Solutions, supports the Patient Services platform and leverages service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Majority from Patient.
Highland Global Allocation Fund is a diversified, closed-end management investment company. The investment objective of the Fund is to seek long-term growth of capital and future income. The Fund seeks to achieve its investment objectives by investing in a portfolio of U.S. and foreign equity, debt, and money market securities. It may also invest in senior loans to domestic or foreign corporations, partnerships, and other entities that operate in a variety of industries and geographic regions.